• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection.

作者信息

Kiehl M G, Stoll R, Broder M, Mueller C, Foerster E C, Domschke W

机构信息

Department of Internal Medicine, University of Münster, Germany.

出版信息

Arch Intern Med. 1996;156(22):2545-50.

PMID:8951297
Abstract

BACKGROUND

Studies on human immunodeficiency virus-infected children suggest that high-dose immune globulin therapy might be beneficial in reducing the episodes of recurrent infections. In adults, comparable studies are not available.

OBJECTIVE

To determine the efficacy of intravenous (IV) immune globulin therapy in preventing infections and reducing days with fever, as well as the duration and frequency of hospitalization for human immunodeficiency virus-infected adults, in a prospective, randomized outpatient clinical trial.

METHODS

Adult patients who met Centers for Disease Control and Prevention criteria B and C were randomized to be treated with (n = 70) or without (n = 57) IV immune globulin. Patients who were assigned to treatment with IV immune globulin received 400 and 200 mg/kg of this drug initially and every 21 days thereafter, respectively. Primary end points were the occurrence of laboratory-proved or clinically diagnosed infections and death caused by infection.

RESULTS

In comparison with patients in the control group, IV immune globulin treatment significantly increased the time for which the patients who met Centers for Disease Control and Prevention criteria B and C were free from serious infection (P < .001). Twelve (17%) of the patients who received IV immune globulin had infection-related deaths compared with 20 (35%) of the control patients; however, this was not statistically significant (P = .06). Furthermore, immune globulin treatment was associated with an overall reduction in the number and duration of hospitalizations for short-term care (P = .002), days with fever (P < .001), and frequency of diarrhea (P < .001). Because of these results, the study was stopped by the local ethical board.

CONCLUSION

Prophylactic IV immune globulin treatment in human immunodeficiency virus-infected adults decreases the frequency of serious infections and is associated with a reduction of hospitalization for short-term care.

摘要

相似文献

1
A controlled trial of intravenous immune globulin for the prevention of serious infections in adults with advanced human immunodeficiency virus infection.
Arch Intern Med. 1996;156(22):2545-50.
2
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.静脉注射免疫球蛋白预防接受齐多夫定治疗的晚期人类免疫缺陷病毒感染儿童严重细菌感染的对照试验。儿科艾滋病临床试验组。
N Engl J Med. 1994 Nov 3;331(18):1181-7. doi: 10.1056/NEJM199411033311802.
3
Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.在日间治疗中心对发热幼儿的尿路感染采用每日静脉注射抗生素疗法进行治疗。
Pediatrics. 2004 Oct;114(4):e469-76. doi: 10.1542/peds.2004-0421.
4
Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.
Pediatr Res. 1993 Jan;33(1 Suppl):S80-7; discussion S87-9. doi: 10.1203/00006450-199305001-00464.
5
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.白细胞介素2联合高效抗逆转录病毒疗法对中度晚期人类免疫缺陷病毒感染患者的病毒学、免疫学及临床影响:一项随机对照临床试验——艾滋病临床试验组328研究
Arch Intern Med. 2007 Mar 26;167(6):597-605. doi: 10.1001/archinte.167.6.597.
6
Does intravenous immune globulin have a role in HIV-infected patients?静脉注射免疫球蛋白在HIV感染患者中起作用吗?
Clin Exp Immunol. 1994 Jul;97 Suppl 1(Suppl 1):59-67.
7
Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.静脉注射免疫球蛋白用于预防有症状的人类免疫缺陷病毒感染儿童的细菌感染。
N Engl J Med. 1991 Jul 11;325(2):73-80. doi: 10.1056/NEJM199107113250201.
8
Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.阿托伐醌与阿奇霉素联合复方磺胺甲恶唑预防HIV感染儿童严重细菌感染的比较
Clin Infect Dis. 2005 Jan 1;40(1):136-45. doi: 10.1086/426074. Epub 2004 Dec 6.
9
A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).一项关于高剂量多价静脉注射免疫球蛋白(HDIgG)与巨细胞病毒(CMV)高免疫球蛋白在异基因造血干细胞移植(HSCT)中的随机试验。
Haematologica. 1998 Feb;83(2):132-7.
10
Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.用于管理住院成年患者短期排尿问题的尿道导管类型:Cochrane系统评价短版
Neurourol Urodyn. 2008;27(8):738-46. doi: 10.1002/nau.20645.